Nov-16 -
Radiation Oncology Group
EORTC 22033/26033 – Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss.
A phase III study.
EORTC found that postoperative chemotherapy and radiotherapy were equally as effective in prolonging progression-free survival in patients with low-grade glioma.